KOLMAR BNH Co.,Ltd. (KOSDAQ:200130)
South Korea · Delayed Price · Currency is KRW 9,430.00
-170.00 (-1.77%)
Aug 31, 2026, 3:30 PM KST
KOLMAR BNH Revenue
KOLMAR BNH had revenue of 136.89B KRW in the quarter ending March 31, 2026, with 0.12% growth. This brings the company's revenue in the last twelve months to 575.05B, down -2.89% year-over-year. In the year 2025, KOLMAR BNH had annual revenue of 574.88B, down -6.62%.
Revenue (ttm)
575.05B
Revenue Growth
-2.89%
P/S Ratio
0.46
Revenue / Employee
1.22B
Employees
472
Market Cap
266.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 574.88B | -40.76B | -6.62% |
| Dec 31, 2024 | 615.64B | 36.09B | 6.23% |
| Dec 31, 2023 | 579.55B | 3.65B | 0.63% |
| Dec 31, 2022 | 575.90B | -17.18B | -2.90% |
| Dec 31, 2021 | 593.08B | -13.81B | -2.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aekyung Industrial | 685.09B |
| Kolmar Holdings | 596.30B |
| VT Co., Ltd. | 471.17B |
| Able C&C | 250.76B |
| Tonymoly | 214.84B |
| It'S Hanbul | 172.16B |
| Monalisa | 140.89B |
| NeoPharm CO., LTD. | 132.18B |
KOLMAR BNH News
- 1 year ago - Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement - Financial Post
- 2 years ago - HemoHim Manufacturer Kolmar BNH Receives NAI Classification from the US FDA - Financial Post